The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Testosterone Injectable Market Research Report 2025
Synopsis
The global Testosterone Injectable market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Testosterone Injectable is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Testosterone Injectable is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Testosterone Injectable include Clarus Therapeutics, Bayer, Endo Pharmaceuticals, Eli Lilly and Company, Kyowa Kirin International, Viatris, Novartis, Pfizer, J & K Scientific, Beijing Coupling Technology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Testosterone Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Injectable.
The Testosterone Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Testosterone Injectable market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Injectable manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Clarus Therapeutics
Bayer
Endo Pharmaceuticals
Eli Lilly and Company
Kyowa Kirin International
Viatris
Novartis
Pfizer
J & K Scientific
Beijing Coupling Technology
Longyan Tianhua Biological Technology
Segment by Type
Testosterone Cypionate
Testosterone Undecanoate
Testosterone Enanthate
Methyl testosterone
Others
Segment by Application
Hospitals
Homecare
Specialty Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Testosterone Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Testosterone Injectable in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Testosterone Injectable market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Testosterone Injectable is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Testosterone Injectable is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Testosterone Injectable include Clarus Therapeutics, Bayer, Endo Pharmaceuticals, Eli Lilly and Company, Kyowa Kirin International, Viatris, Novartis, Pfizer, J & K Scientific, Beijing Coupling Technology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Testosterone Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Injectable.
The Testosterone Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Testosterone Injectable market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Injectable manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Clarus Therapeutics
Bayer
Endo Pharmaceuticals
Eli Lilly and Company
Kyowa Kirin International
Viatris
Novartis
Pfizer
J & K Scientific
Beijing Coupling Technology
Longyan Tianhua Biological Technology
Segment by Type
Testosterone Cypionate
Testosterone Undecanoate
Testosterone Enanthate
Methyl testosterone
Others
Segment by Application
Hospitals
Homecare
Specialty Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Testosterone Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Testosterone Injectable in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Testosterone Injectable Market Overview
1.1 Product Definition
1.2 Testosterone Injectable by Type
1.2.1 Global Testosterone Injectable Market Value Comparison by Type (2024-2030)
1.2.2 Testosterone Cypionate
1.2.3 Testosterone Undecanoate
1.2.4 Testosterone Enanthate
1.2.5 Methyl testosterone
1.2.6 Others
1.3 Testosterone Injectable by Application
1.3.1 Global Testosterone Injectable Market Value by Application (2024-2030)
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Testosterone Injectable Market Size Estimates and Forecasts
1.4.1 Global Testosterone Injectable Revenue 2019-2030
1.4.2 Global Testosterone Injectable Sales 2019-2030
1.4.3 Global Testosterone Injectable Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Testosterone Injectable Market Competition by Manufacturers
2.1 Global Testosterone Injectable Sales Market Share by Manufacturers (2019-2024)
2.2 Global Testosterone Injectable Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Testosterone Injectable Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Testosterone Injectable, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Testosterone Injectable, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Testosterone Injectable, Product Type & Application
2.7 Global Key Manufacturers of Testosterone Injectable, Date of Enter into This Industry
2.8 Global Testosterone Injectable Market Competitive Situation and Trends
2.8.1 Global Testosterone Injectable Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Testosterone Injectable Players Market Share by Revenue
2.8.3 Global Testosterone Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Testosterone Injectable Market Scenario by Region
3.1 Global Testosterone Injectable Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Testosterone Injectable Sales by Region: 2019-2030
3.2.1 Global Testosterone Injectable Sales by Region: 2019-2024
3.2.2 Global Testosterone Injectable Sales by Region: 2025-2030
3.3 Global Testosterone Injectable Revenue by Region: 2019-2030
3.3.1 Global Testosterone Injectable Revenue by Region: 2019-2024
3.3.2 Global Testosterone Injectable Revenue by Region: 2025-2030
3.4 North America Testosterone Injectable Market Facts & Figures by Country
3.4.1 North America Testosterone Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Testosterone Injectable Sales by Country (2019-2030)
3.4.3 North America Testosterone Injectable Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Testosterone Injectable Market Facts & Figures by Country
3.5.1 Europe Testosterone Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Testosterone Injectable Sales by Country (2019-2030)
3.5.3 Europe Testosterone Injectable Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Testosterone Injectable Market Facts & Figures by Region
3.6.1 Asia Pacific Testosterone Injectable Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Testosterone Injectable Sales by Region (2019-2030)
3.6.3 Asia Pacific Testosterone Injectable Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Testosterone Injectable Market Facts & Figures by Country
3.7.1 Latin America Testosterone Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Testosterone Injectable Sales by Country (2019-2030)
3.7.3 Latin America Testosterone Injectable Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Testosterone Injectable Market Facts & Figures by Country
3.8.1 Middle East and Africa Testosterone Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Testosterone Injectable Sales by Country (2019-2030)
3.8.3 Middle East and Africa Testosterone Injectable Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Testosterone Injectable Sales by Type (2019-2030)
4.1.1 Global Testosterone Injectable Sales by Type (2019-2024)
4.1.2 Global Testosterone Injectable Sales by Type (2025-2030)
4.1.3 Global Testosterone Injectable Sales Market Share by Type (2019-2030)
4.2 Global Testosterone Injectable Revenue by Type (2019-2030)
4.2.1 Global Testosterone Injectable Revenue by Type (2019-2024)
4.2.2 Global Testosterone Injectable Revenue by Type (2025-2030)
4.2.3 Global Testosterone Injectable Revenue Market Share by Type (2019-2030)
4.3 Global Testosterone Injectable Price by Type (2019-2030)
5 Segment by Application
5.1 Global Testosterone Injectable Sales by Application (2019-2030)
5.1.1 Global Testosterone Injectable Sales by Application (2019-2024)
5.1.2 Global Testosterone Injectable Sales by Application (2025-2030)
5.1.3 Global Testosterone Injectable Sales Market Share by Application (2019-2030)
5.2 Global Testosterone Injectable Revenue by Application (2019-2030)
5.2.1 Global Testosterone Injectable Revenue by Application (2019-2024)
5.2.2 Global Testosterone Injectable Revenue by Application (2025-2030)
5.2.3 Global Testosterone Injectable Revenue Market Share by Application (2019-2030)
5.3 Global Testosterone Injectable Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Clarus Therapeutics
6.1.1 Clarus Therapeutics Company Information
6.1.2 Clarus Therapeutics Description and Business Overview
6.1.3 Clarus Therapeutics Testosterone Injectable Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Clarus Therapeutics Testosterone Injectable Product Portfolio
6.1.5 Clarus Therapeutics Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Testosterone Injectable Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Testosterone Injectable Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Endo Pharmaceuticals
6.3.1 Endo Pharmaceuticals Company Information
6.3.2 Endo Pharmaceuticals Description and Business Overview
6.3.3 Endo Pharmaceuticals Testosterone Injectable Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Endo Pharmaceuticals Testosterone Injectable Product Portfolio
6.3.5 Endo Pharmaceuticals Recent Developments/Updates
6.4 Eli Lilly and Company
6.4.1 Eli Lilly and Company Company Information
6.4.2 Eli Lilly and Company Description and Business Overview
6.4.3 Eli Lilly and Company Testosterone Injectable Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly and Company Testosterone Injectable Product Portfolio
6.4.5 Eli Lilly and Company Recent Developments/Updates
6.5 Kyowa Kirin International
6.5.1 Kyowa Kirin International Company Information
6.5.2 Kyowa Kirin International Description and Business Overview
6.5.3 Kyowa Kirin International Testosterone Injectable Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kyowa Kirin International Testosterone Injectable Product Portfolio
6.5.5 Kyowa Kirin International Recent Developments/Updates
6.6 Viatris
6.6.1 Viatris Company Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris Testosterone Injectable Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Viatris Testosterone Injectable Product Portfolio
6.6.5 Viatris Recent Developments/Updates
6.7 Novartis
6.7.1 Novartis Company Information
6.7.2 Novartis Description and Business Overview
6.7.3 Novartis Testosterone Injectable Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Novartis Testosterone Injectable Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Testosterone Injectable Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Testosterone Injectable Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 J & K Scientific
6.9.1 J & K Scientific Company Information
6.9.2 J & K Scientific Description and Business Overview
6.9.3 J & K Scientific Testosterone Injectable Sales, Revenue and Gross Margin (2019-2024)
6.9.4 J & K Scientific Testosterone Injectable Product Portfolio
6.9.5 J & K Scientific Recent Developments/Updates
6.10 Beijing Coupling Technology
6.10.1 Beijing Coupling Technology Company Information
6.10.2 Beijing Coupling Technology Description and Business Overview
6.10.3 Beijing Coupling Technology Testosterone Injectable Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Beijing Coupling Technology Testosterone Injectable Product Portfolio
6.10.5 Beijing Coupling Technology Recent Developments/Updates
6.11 Longyan Tianhua Biological Technology
6.11.1 Longyan Tianhua Biological Technology Company Information
6.11.2 Longyan Tianhua Biological Technology Description and Business Overview
6.11.3 Longyan Tianhua Biological Technology Testosterone Injectable Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Longyan Tianhua Biological Technology Testosterone Injectable Product Portfolio
6.11.5 Longyan Tianhua Biological Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Testosterone Injectable Industry Chain Analysis
7.2 Testosterone Injectable Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Testosterone Injectable Production Mode & Process
7.4 Testosterone Injectable Sales and Marketing
7.4.1 Testosterone Injectable Sales Channels
7.4.2 Testosterone Injectable Distributors
7.5 Testosterone Injectable Customers
8 Testosterone Injectable Market Dynamics
8.1 Testosterone Injectable Industry Trends
8.2 Testosterone Injectable Market Drivers
8.3 Testosterone Injectable Market Challenges
8.4 Testosterone Injectable Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Testosterone Injectable Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Testosterone Injectable Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Testosterone Injectable Market Competitive Situation by Manufacturers in 2023
Table 4. Global Testosterone Injectable Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Testosterone Injectable Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Testosterone Injectable Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Testosterone Injectable Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Testosterone Injectable Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Testosterone Injectable, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Testosterone Injectable, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Testosterone Injectable, Product Type & Application
Table 12. Global Key Manufacturers of Testosterone Injectable, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Testosterone Injectable by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Injectable as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Testosterone Injectable Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Testosterone Injectable Sales by Region (2019-2024) & (K Units)
Table 18. Global Testosterone Injectable Sales Market Share by Region (2019-2024)
Table 19. Global Testosterone Injectable Sales by Region (2025-2030) & (K Units)
Table 20. Global Testosterone Injectable Sales Market Share by Region (2025-2030)
Table 21. Global Testosterone Injectable Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Testosterone Injectable Revenue Market Share by Region (2019-2024)
Table 23. Global Testosterone Injectable Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Testosterone Injectable Revenue Market Share by Region (2025-2030)
Table 25. North America Testosterone Injectable Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Testosterone Injectable Sales by Country (2019-2024) & (K Units)
Table 27. North America Testosterone Injectable Sales by Country (2025-2030) & (K Units)
Table 28. North America Testosterone Injectable Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Testosterone Injectable Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Testosterone Injectable Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Testosterone Injectable Sales by Country (2019-2024) & (K Units)
Table 32. Europe Testosterone Injectable Sales by Country (2025-2030) & (K Units)
Table 33. Europe Testosterone Injectable Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Testosterone Injectable Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Testosterone Injectable Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Testosterone Injectable Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Testosterone Injectable Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Testosterone Injectable Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Testosterone Injectable Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Testosterone Injectable Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Testosterone Injectable Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Testosterone Injectable Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Testosterone Injectable Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Testosterone Injectable Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Testosterone Injectable Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Testosterone Injectable Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Testosterone Injectable Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Testosterone Injectable Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Testosterone Injectable Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Testosterone Injectable Sales (K Units) by Type (2019-2024)
Table 51. Global Testosterone Injectable Sales (K Units) by Type (2025-2030)
Table 52. Global Testosterone Injectable Sales Market Share by Type (2019-2024)
Table 53. Global Testosterone Injectable Sales Market Share by Type (2025-2030)
Table 54. Global Testosterone Injectable Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Testosterone Injectable Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Testosterone Injectable Revenue Market Share by Type (2019-2024)
Table 57. Global Testosterone Injectable Revenue Market Share by Type (2025-2030)
Table 58. Global Testosterone Injectable Price (US$/Unit) by Type (2019-2024)
Table 59. Global Testosterone Injectable Price (US$/Unit) by Type (2025-2030)
Table 60. Global Testosterone Injectable Sales (K Units) by Application (2019-2024)
Table 61. Global Testosterone Injectable Sales (K Units) by Application (2025-2030)
Table 62. Global Testosterone Injectable Sales Market Share by Application (2019-2024)
Table 63. Global Testosterone Injectable Sales Market Share by Application (2025-2030)
Table 64. Global Testosterone Injectable Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Testosterone Injectable Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Testosterone Injectable Revenue Market Share by Application (2019-2024)
Table 67. Global Testosterone Injectable Revenue Market Share by Application (2025-2030)
Table 68. Global Testosterone Injectable Price (US$/Unit) by Application (2019-2024)
Table 69. Global Testosterone Injectable Price (US$/Unit) by Application (2025-2030)
Table 70. Clarus Therapeutics Company Information
Table 71. Clarus Therapeutics Description and Business Overview
Table 72. Clarus Therapeutics Testosterone Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Clarus Therapeutics Testosterone Injectable Product
Table 74. Clarus Therapeutics Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Testosterone Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bayer Testosterone Injectable Product
Table 79. Bayer Recent Developments/Updates
Table 80. Endo Pharmaceuticals Company Information
Table 81. Endo Pharmaceuticals Description and Business Overview
Table 82. Endo Pharmaceuticals Testosterone Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Endo Pharmaceuticals Testosterone Injectable Product
Table 84. Endo Pharmaceuticals Recent Developments/Updates
Table 85. Eli Lilly and Company Company Information
Table 86. Eli Lilly and Company Description and Business Overview
Table 87. Eli Lilly and Company Testosterone Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Eli Lilly and Company Testosterone Injectable Product
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. Kyowa Kirin International Company Information
Table 91. Kyowa Kirin International Description and Business Overview
Table 92. Kyowa Kirin International Testosterone Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Kyowa Kirin International Testosterone Injectable Product
Table 94. Kyowa Kirin International Recent Developments/Updates
Table 95. Viatris Company Information
Table 96. Viatris Description and Business Overview
Table 97. Viatris Testosterone Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Viatris Testosterone Injectable Product
Table 99. Viatris Recent Developments/Updates
Table 100. Novartis Company Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Testosterone Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Novartis Testosterone Injectable Product
Table 104. Novartis Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Testosterone Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Pfizer Testosterone Injectable Product
Table 109. Pfizer Recent Developments/Updates
Table 110. J & K Scientific Company Information
Table 111. J & K Scientific Description and Business Overview
Table 112. J & K Scientific Testosterone Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. J & K Scientific Testosterone Injectable Product
Table 114. J & K Scientific Recent Developments/Updates
Table 115. Beijing Coupling Technology Company Information
Table 116. Beijing Coupling Technology Description and Business Overview
Table 117. Beijing Coupling Technology Testosterone Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Beijing Coupling Technology Testosterone Injectable Product
Table 119. Beijing Coupling Technology Recent Developments/Updates
Table 120. Longyan Tianhua Biological Technology Company Information
Table 121. Longyan Tianhua Biological Technology Description and Business Overview
Table 122. Longyan Tianhua Biological Technology Testosterone Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Longyan Tianhua Biological Technology Testosterone Injectable Product
Table 124. Longyan Tianhua Biological Technology Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Testosterone Injectable Distributors List
Table 128. Testosterone Injectable Customers List
Table 129. Testosterone Injectable Market Trends
Table 130. Testosterone Injectable Market Drivers
Table 131. Testosterone Injectable Market Challenges
Table 132. Testosterone Injectable Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Testosterone Injectable
Figure 2. Global Testosterone Injectable Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Testosterone Injectable Market Share by Type: 2023 & 2030
Figure 4. Testosterone Cypionate Product Picture
Figure 5. Testosterone Undecanoate Product Picture
Figure 6. Testosterone Enanthate Product Picture
Figure 7. Methyl testosterone Product Picture
Figure 8. Others Product Picture
Figure 9. Global Testosterone Injectable Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Testosterone Injectable Market Share by Application: 2023 & 2030
Figure 11. Hospitals
Figure 12. Homecare
Figure 13. Specialty Clinics
Figure 14. Others
Figure 15. Global Testosterone Injectable Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Testosterone Injectable Market Size (2019-2030) & (US$ Million)
Figure 17. Global Testosterone Injectable Sales (2019-2030) & (K Units)
Figure 18. Global Testosterone Injectable Average Price (US$/Unit) & (2019-2030)
Figure 19. Testosterone Injectable Report Years Considered
Figure 20. Testosterone Injectable Sales Share by Manufacturers in 2023
Figure 21. Global Testosterone Injectable Revenue Share by Manufacturers in 2023
Figure 22. Global 5 and 10 Largest Testosterone Injectable Players: Market Share by Revenue in Testosterone Injectable in 2023
Figure 23. Testosterone Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 24. Global Testosterone Injectable Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Testosterone Injectable Sales Market Share by Country (2019-2030)
Figure 26. North America Testosterone Injectable Revenue Market Share by Country (2019-2030)
Figure 27. United States Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Testosterone Injectable Sales Market Share by Country (2019-2030)
Figure 30. Europe Testosterone Injectable Revenue Market Share by Country (2019-2030)
Figure 31. Germany Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Testosterone Injectable Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Testosterone Injectable Revenue Market Share by Region (2019-2030)
Figure 38. China Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Testosterone Injectable Sales Market Share by Country (2019-2030)
Figure 46. Mexico Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East and Africa Testosterone Injectable Sales Market Share by Country (2019-2030)
Figure 51. Middle East and Africa Testosterone Injectable Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Testosterone Injectable Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Testosterone Injectable by Type (2019-2030)
Figure 56. Global Revenue Market Share of Testosterone Injectable by Type (2019-2030)
Figure 57. Global Testosterone Injectable Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Testosterone Injectable by Application (2019-2030)
Figure 59. Global Revenue Market Share of Testosterone Injectable by Application (2019-2030)
Figure 60. Global Testosterone Injectable Price (US$/Unit) by Application (2019-2030)
Figure 61. Testosterone Injectable Value Chain
Figure 62. Testosterone Injectable Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
